par Bartova, Lucie;Fugger, G.;Dold, Markus;Kautzky, Alexander;Swoboda, Marleen Margret Mignon;Rujescu, Dan;Zohar, Joseph;Souery, Daniel
;Mendlewicz, Julien
;Montgomery, Stuart;Fabbri, Chiara;Serretti, Alessandro;Kasper, Siegfried S.F.
Référence The international journal of neuropsychopharmacology, 25, 2, page (118-127)
Publication Publié, 2022-02
;Mendlewicz, Julien
;Montgomery, Stuart;Fabbri, Chiara;Serretti, Alessandro;Kasper, Siegfried S.F.Référence The international journal of neuropsychopharmacology, 25, 2, page (118-127)
Publication Publié, 2022-02
Article révisé par les pairs
| Titre: |
|
| Auteur: | Bartova, Lucie; Fugger, G.; Dold, Markus; Kautzky, Alexander; Swoboda, Marleen Margret Mignon; Rujescu, Dan; Zohar, Joseph; Souery, Daniel; Mendlewicz, Julien; Montgomery, Stuart; Fabbri, Chiara; Serretti, Alessandro; Kasper, Siegfried S.F. |
| Informations sur la publication: | The international journal of neuropsychopharmacology, 25, 2, page (118-127) |
| Statut de publication: | Publié, 2022-02 |
| Sujet CREF: | Psychiatrie |
| Pharmacologie | |
| Mots-clés: | Antidepressant treatment |
| aripiprazole | |
| augmentation | |
| major depressive disorder | |
| quetiapine | |
| second-generation antipsychotics | |
| Note générale: | SCOPUS: ar.j |
| Langue: | Anglais |
| Identificateurs: | urn:issn:1469-5111 |
| info:doi/10.1093/ijnp/pyab066 | |
| info:scp/85124498647 | |
| info:pmid/34637516 |



